Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 10 of 42 for:    FROVATRIPTAN

Oxygenation Via Frova Bougie and Ambu Bag

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02786355
Recruitment Status : Completed
First Posted : June 1, 2016
Results First Posted : December 28, 2018
Last Update Posted : December 28, 2018
Sponsor:
Information provided by (Responsible Party):
Simon Massey, University of British Columbia

Brief Summary:
We will conduct this study to show that it is possible to deliver air through a Frova bougie and an Ambu® bag.

Condition or disease Intervention/treatment Phase
Failed or Difficult Intubation Other: Frova bougie Not Applicable

Detailed Description:
Participants will be invited to squeeze an Ambu® bag connected to a Frova bougie, and we will measure the volume of air delivered and peak pressure generated.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 35 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Double (Participant, Outcomes Assessor)
Primary Purpose: Other
Official Title: Comparison of Volumes of Air Delivered Through a Frova Intubation Bougie by a Maximal Bimanual Compression Versus a Normal Bimanual Compression of an Adult Ambu® Bag
Study Start Date : February 2016
Actual Primary Completion Date : March 2016
Actual Study Completion Date : March 2016

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Maximum bimanual compression
Squeeze through Frova bougie with maximum bimanual compression
Other: Frova bougie
Squeezing an Ambu bag and delivering air through a Frova bougie. Measuring mean volumes of air delivered and peak pressures generated.

Normal bimanual compression
Squeeze through Frova bougie with normal bimanual compression
Other: Frova bougie
Squeezing an Ambu bag and delivering air through a Frova bougie. Measuring mean volumes of air delivered and peak pressures generated.




Primary Outcome Measures :
  1. Tidal Volume (ml) [ Time Frame: 15 minutes ]
    volume of air delivered via Frova bougie (milliliters)



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • staff, fellows and resident anesthesiologists

Exclusion Criteria:

  • injury to hand

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02786355


Locations
Layout table for location information
Canada, British Columbia
BC Women's Hospital
Vancouver, British Columbia, Canada, V5X1T3
Sponsors and Collaborators
University of British Columbia
Investigators
Layout table for investigator information
Principal Investigator: Simon Massey, FRCPC BC Women's Hospital,UBC

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Simon Massey, Principal Investigator, University of British Columbia
ClinicalTrials.gov Identifier: NCT02786355     History of Changes
Other Study ID Numbers: H15-03391
First Posted: June 1, 2016    Key Record Dates
Results First Posted: December 28, 2018
Last Update Posted: December 28, 2018
Last Verified: June 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Frovatriptan
Serotonin Receptor Agonists
Serotonin Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Physiological Effects of Drugs